Supe, Lyciel P.

HRN: 12-41-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
CEFUROXIME 1.5GM (VIAL)
05/05/2025
05/12/2025
IVT
1.5 GMS
Q8
INCOMPLETE ABORTION
Waiting Final Action 
05/05/2025
METRONIDAZOLE 500MG (TAB)
05/05/2025
05/12/2025
IVT
500 MG
Q 8
INCOMPLETE ABORTION
Waiting Final Action 
05/05/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/05/2025
05/12/2025
IVT
500 MG
Q8
INCOMPLETE ABORTION
Waiting Final Action 
05/07/2025
CEFUROXIME 500MG (TAB)
05/07/2025
05/13/2025
ORAL
500mg
2 Times A Day
S/P Completion Curettage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: